While the etiology of IPF is unknown, preventing injury/damage to the epithelium barrier and consequent expansion of fibroblast and extracellular matrix is an appropriate step in the right direction.
There is ample evidence to justify investigating ET-1 blockade as a therapeutic approach in IPF. Data From Animal Studies. Transgenic mice with lung-specific overexpression of the human gene for ...
The multiple-Grammy Award winner reportedly died due to Idiopathic Pulmonary Fibrosis (IPF). Let’s delve into rare disease that claimed the maestro's life. IPF is a chronic and progressive lung ...
Current IPF cough treatments are often inadequate, highlighting the need for improved therapeutic strategies and a deeper understanding of underlying mechanisms. The study identifies potential ...
"Moreover, the profile of the statistically significant changes in the biomarkers in response to LTI-03 treatment also suggests that LTI-03 may not only act on fibroblasts, but also on epithelial ...